Clinical Trial Update: App-Assisted Day Reconstruction to Reduce Treatment Burden and Logistic Toxicity in Cancer Patients - Aim 3

View source ↗

Summary

This update notes the completion of Aim 3 for a cancer trial evaluating app-assisted day reconstruction to reduce treatment burden and logistical toxicity in ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: Daynamica, Inc. | Conditions: Cancer | Status: COMPLETED